Microarray-based molecular diagnostics: High-throughput identification of bloodborne pathogens for the control and management of disease

基于微阵列的分子诊断：高通量鉴定血源性病原体以控制和管理疾病

• 批准号: 488680-2015
• 负责人: Milstein, Joshua
• 金额: $ 1.82万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Engage Grants Program
• 财政年份: 2015
• 资助国家: 加拿大
• 起止时间: 2015-01-01 至 2016-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=586365
• 关键词: Microarray; based; molecular; diagnostics; throughput

The Toronto based company Safeguard Biosystems (SGBio) is developing a reusable microarray-based molecular diagnostic platform for identifying bloodborne pathogenic bacteria. SGBio's unique molecular assay has the potential to replace the current standard of cell-culture based assays. Their approach offers a tremendous advantage in both reliability and efficiency of diagnosis. SGBio is looking to collaborate on the development of a Bioinformatics software platform to incorporate into their device. The software will improve the effectiveness of their product and streamline the throughput of their product workflow. Successful completion of this project will allow SGBio to bring their molecular diagnostic platform to market in the next 1-2 years, provide valuable training to HQP, and lead to significant R&D growth within the Toronto/Mississauga regions.

总部位于多伦多的公司保障生物系统（SGBIO）正在开发可重复使用的基于微阵列的分子诊断平台，用于鉴定血源性的致病细菌。 SGBIO的独特分子测定有可能替代当前基于细胞培养的测定标准。他们的方法在诊断的可靠性和效率方面都具有巨大的优势。 SGBIO希望合作开发生物信息学软件平台，以纳入其设备。该软件将提高产品的有效性，并简化其产品工作流程的吞吐量。该项目的成功完成将使SGBIO能够在未来1 - 2年内将其分子诊断平台推向市场，为HQP提供宝贵的培训，并在多伦多/密西沙加地区提供大量的研发增长。